Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses

Biomark Med. 2014;8(1):9-14. doi: 10.2217/bmm.13.133.

Abstract

“As the clarification and development of neurophysiological biomarkers continues, shifts in our approach to diagnosis and treatment decisions should follow. After all, the success of precision medicine lies within these neuroscientific advances, and will likely be the roadmap to a next-generation brain-based Diagnostic and Statistical Manual.”

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Algorithms
  • Antipsychotic Agents / therapeutic use
  • Biomarkers / metabolism*
  • Humans
  • Psychotic Disorders / diagnosis*
  • Psychotic Disorders / drug therapy
  • Risk Factors

Substances

  • Antipsychotic Agents
  • Biomarkers